Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Naviscan Inc. to Present at BIOCOM Investor Conference in San Diego on October 27th, 2009

Naviscan , Inc., the leader in Molecular Breast Imaging (MBI), announced that Paul J. Mirabella, President and Chief Executive Officer, will be presenting a corporate update at the 4th Annual BIOCOM Investor Conference on October 27, 2009 at 1:00 p.m. being held at Hyatt Regency in La Jolla, California.

The presentation will include a summary of a 388-patient, NIH-sponsored clinical trial comparing their high-resolution breast PET system, Positron Emission Mammography (PEM) scanner, to breast Magnetic Resonance (MR).

"These exciting results, especially during Breast Cancer Awareness Month, will be welcomed news by patients and physicians as a new and effective tool in management of the breast cancer patient," said Mirabella.

About Naviscan , Inc.
Naviscan Inc., founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging, guide radiological and surgical procedures and advance new clinical therapies. For more information visit www.naviscan.com.

Source: Naviscan

You can discuss about Naviscan and its services in the Naviscan Company User Group